Barry Ticho's Net Worth
$3.33 Million
Who is Barry Ticho?
Barry Ticho has an estimated net worth of $3.33 Million. This is based on reported shares across multiple companies, which include Stoke Therapeutics, Inc., and Verve Therapeutics, Inc..
SEC CIK
Barry Ticho's CIK is 0001780088
Past Insider Trading and Trends
2024 was Barry Ticho's most active year for acquiring shares with 9 total transactions. Barry Ticho's most active month to acquire stocks was the month of February. 2024 was Barry Ticho's most active year for disposing of shares, totalling 18 transactions. Barry Ticho's most active month to dispose stocks was the month of May. 2020 saw Barry Ticho paying a total of $175,584.75 for 235,392 shares, this is the most they've acquired in one year. In 2021 Barry Ticho cashed out on 43,166 shares for a total of $1,413,654.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Stoke Therapeutics, Inc. (STOK) Snapshot price: $14.7
CHIEF MEDICAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$6.64 | -$120,803.00 | 2.48K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$7.78 | -$143,480.76 | 2.48K |
Scheduled
|
Sep 3
| ||
Form 4
|
—
|
0
|
$7.18 | -$131,458.00 | 2.48K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
|
—
|
0
|
$7.91 | -$146,185.43 | 2.48K |
Scheduled
|
Jun 3
| ||
Form 4
|
—
|
0
|
$5.99 | -$107,653.00 | 2.48K |
Scheduled
|
May 1
| ||
Form 4
| -78.33% | -8.98K |
$6.92 | -$124,419.10 | 2.48K |
Scheduled
|
Apr 1
| ||
Form 4
| +361.53% | 8.98K |
$6.10 | -$25,101.84 | 11.47K |
Mar 15 - Mar 19
| |||
Form 4
| -64.40% | -4.50K |
$4.18 | -$74,166.60 | 2.48K |
Scheduled
|
Mar 1
| ||
Form 4
| -58.89% | -10.00K |
$4.80 | -$47,991.00 | 6.98K |
Scheduled
|
Feb 1
| ||
Form 4
| -37.06% | -10.00K |
$5.74 | -$57,352.00 | 16.98K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
| -36.68% | -15.00K |
$10.60 | -$158,973.00 | 25.89K |
Jul 3
| |||
Form 4
| -26.84% | -15.00K |
$11.13 | -$166,963.50 | 40.9K |
Jun 1
| |||
Form 4
| -1.15% | -653.00 |
$10.00 | -$6,530.00 | 55.9K |
May 4
| |||
Form 4
| -49.39% | -55.18K |
$10.06 | -$555,267.07 | 56.55K |
May 1 - May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| -10.42% | -13.00K |
$10.02 | -$130,236.44 | 111.72K |
Scheduled
|
Feb 3 - Feb 6
| ||
Form 4
| -4.72% | -6.17K |
$10.01 | -$61,810.14 | 124.72K |
Scheduled
|
Jan 31 - Feb 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| -24.80% | -43.17K |
$32.75 | -$1,413,654.08 | 130.9K |
Scheduled
|
Jul 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
$29.90 | -$75,664.70 | 173.4K |
Scheduled
|
Dec 21
| ||
Form 4
|
∞
| 172.66K |
$14.19 | $135,208.70 | 172.66K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||